A phase II study of M-azido-pyrimethamine ethane sulphonate (MZPES) in advanced, recurrent soft tissue sarcoma. An EORTC Soft Tissue and Bone Sarcoma Group Study

MeSH terms

• Adult
• Aged
• Azides / adverse effects
• Azides / therapeutic use*
• Drug Evaluation
• Female
• Humans
• Male
• Middle Aged
• Neoplasm Metastasis
• Pyrimethamine / adverse effects
• Pyrimethamine / analogs & derivatives*
• Pyrimethamine / therapeutic use
• Sarcoma / drug therapy*
• Soft Tissue Neoplasms / drug therapy*